Structural Neuroimaging in Aging and Alzheimer's Disease

Neuroimaging Clinics of North America

Volumn 22, Issue 1, 2012, Pages 33-55

  Vernooij, Meike W ^a   Smits, Marion ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Atrophy; Brain; Dementia; Magnetic resonance (MR) imaging; Neuroimaging; Normal aging

Indexed keywords

BIOLOGICAL MARKER;

AGING; ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN DAMAGE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; FRACTIONAL ANISOTROPY; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROIMAGING; PRIORITY JOURNAL; REVIEW; SUBARACHNOID SPACE; SUSCEPTIBILITY WEIGHTED IMAGING; WHITE MATTER;

AGING; ALZHEIMER DISEASE; BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROIMAGING;

EID: 84856267899     PISSN: 10525149     EISSN: 15579867     Source Type: Journal    
DOI: 10.1016/j.nic.2011.11.007     Document Type: Review

References (96)

1. Dubois B., Feldman H.H., Jacova C., et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007, 6(8):734-746.
2. Pelletier D., Garrison K., Henry R. Measurement of whole-brain atrophy in multiple sclerosis. J Neuroimaging 2004, 14(Suppl 3):11S-19S.
3. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. Neuroimage 2000, 11(6 Pt 1):805-821.
4. de Boer R., Vrooman H.A., van der Lijn F., et al. White matter lesion extension to automatic brain tissue segmentation on MRI. Neuroimage 2009, 45(4):1151-1161.
5. Smith S.M., Rao A., De Stefano N., et al. Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX. Neuroimage 2007, 36(4):1200-1206.
6. Freeborough P.A., Fox N.C. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans Med Imaging 1997, 16(5):623-629.
7. de Boer R., Vrooman H.A., Ikram M.A., et al. Accuracy and reproducibility study of automatic MRI brain tissue segmentation methods. Neuroimage 2010, 51(3):1047-1056.
8. DeCarli C., Massaro J., Harvey D., et al. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging 2005, 26(4):491-510.
9. Ikram M.A., Vrooman H.A., Vernooij M.W., et al. Brain tissue volumes in the general elderly population. The Rotterdam Scan Study. Neurobiol Aging 2008, 29(6):882-890.
10. Enzinger C., Fazekas F., Matthews P.M., et al. Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 2005, 64(10):1704-1711.
11. Allen J.S., Bruss J., Brown C.K., et al. Normal neuroanatomical variation due to age: the major lobes and a parcellation of the temporal region. Neurobiol Aging 2005, 26(9):1245-1260. [discussion: 1279-82].
12. Fotenos A.F., Snyder A.Z., Girton L.E., et al. Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD. Neurology 2005, 64(6):1032-1039.
13. Jernigan T.L., Archibald S.L., Fennema-Notestine C., et al. Effects of age on tissues and regions of the cerebrum and cerebellum. Neurobiol Aging 2001, 22(4):581-594.
14. Liu R.S., Lemieux L., Bell G.S., et al. Alongitudinal study of brain morphometrics using quantitative magnetic resonance imaging and difference image analysis. Neuroimage 2003, 20(1):22-33.
15. Schmidt R., Ropele S., Enzinger C., et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol 2005, 58(4):610-616.
16. Konrad C., Ukas T., Nebel C., et al. Defining the human hippocampus in cerebral magnetic resonance images-an overview of current segmentation protocols. Neuroimage 2009, 47(4):1185-1195.
17. van der Lijn F., den Heijer T., Breteler M.M., et al. Hippocampus segmentation in MR images using atlas registration, voxel classification, and graph cuts. Neuroimage 2008, 43(4):708-720.
18. Leung K.K., Barnes J., Ridgway G.R., et al. Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease. Neuroimage 2010, 51(4):1345-1359.
19. den Heijer T., van der Lijn F., Koudstaal P.J., et al. A10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. Brain 2010, 133(Pt 4):1163-1172.
20. Barnes J., Bartlett J.W., Van De Pol L.A., et al. Ameta-analysis of hippocampal atrophy rates in Alzheimer's disease. Neurobiol Aging 2009, 30(11):1711-1723.
21. Fazekas F., Chawluk J.B., Alavi A., et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987, 149(2):351-356.
22. Wahlund L.O., Barkhof F., Fazekas F., et al. Anew rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001, 32(6):1318-1322.
23. Scheltens P., Barkhof F., Leys D., et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. JNeurol Sci 1993, 114(1):7-12.
24. Kapeller P., Barber R., Vermeulen R.J., et al. Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke 2003, 34(2):441-445.
25. Mantyla R., Erkinjuntti T., Salonen O., et al. Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. Stroke 1997, 28(8):1614-1623.
26. Pantoni L., Garcia J.H. Pathogenesis of leukoaraiosis: a review. Stroke 1997, 28(3):652-659.
27. Patel B., Markus H.S. Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker. Int J Stroke 2011, 6(1):47-59.
28. Debette S., Markus H.S. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010, 341:c3666.
29. Barkhof F., van Walderveen M. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance. Philos Trans R Soc Lond B Biol Sci 1999, 354(1390):1675-1686.
30. Basser P.J., Jones D.K. Diffusion-tensor MRI: theory, experimental design and data analysis-a technical review. NMR Biomed 2002, 15(7-8):456-467.
31. Salat D.H., Tuch D.S., Greve D.N., et al. Age-related alterations in white matter microstructure measured by diffusion tensor imaging. Neurobiol Aging 2005, 26(8):1215-1227.
32. Sullivan E.V., Pfefferbaum A. Diffusion tensor imaging and aging. Neurosci Biobehav Rev 2006, 30(6):749-761.
33. Vernooij M.W., de Groot M., van der Lugt A., et al. White matter atrophy and lesion formation explain the loss of structural integrity of white matter in aging. Neuroimage 2008, 43(3):470-477.
34. Vernooij M.W., Ikram M.A., Vrooman H.A., et al. White matter microstructural integrity and cognitive function in a general elderly population. Arch Gen Psychiatry 2009, 66(5):545-553.
35. Charlton R.A., Barrick T.R., McIntyre D.J., et al. White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology 2006, 66(2):217-222.
36. O'Sullivan M., Jones D.K., Summers P.E., et al. Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline. Neurology 2001, 57(4):632-638.
37. Offenbacher H., Fazekas F., Schmidt R., et al. MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol 1996, 17(3):573-578.
38. Scheid R., Ott D.V., Roth H., et al. Comparative magnetic resonance imaging at 1.5 and 3 Tesla for the evaluation of traumatic microbleeds. J Neurotrauma 2007, 24(12):1811-1816.
39. Vernooij M.W., Ikram M.A., Wielopolski P.A., et al. Cerebral microbleeds: accelerated 3D T2*-weighted GRE MR imaging versus conventional 2D T2*-weighted GRE MR imaging for detection. Radiology 2008, 248(1):272-277.
40. Sehgal V., Delproposto Z., Haacke E.M., et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. JMagn Reson Imaging 2005, 22(4):439-450.
41. Vernooij M.W., van der Lugt A., Ikram M.A., et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008, 70(14):1208-1214.
42. Poels M.M., Vernooij M.W., Ikram M.A., et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke 2010, 41(Suppl 10):S103-S106.
43. Mesker D.J., Poels M.M., Ikram M.A., et al. Lobar distribution of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol 2011, 68(5):656-659.
44. Qiu C., Cotch M.F., Sigurdsson S., et al. Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology 2010, 75(24):2221-2228.
45. Poels MM, Ikram MA, Van der Lugt A, et al. Cerebral microbleeds are associated with worse cognitive function. The Rotterdam Scan Study. Neurology, in press.
46. Goos J.D., Kester M.I., Barkhof F., et al. Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. Stroke 2009, 40(11):3455-3460.
47. Poels M.M., Ikram M.A., van der Lugt A., et al. Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke 2011, 42(3):656-661.
48. Goos J.D., Henneman W.J., Sluimer J.D., et al. Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population. Neurology 2010, 74(24):1954-1960.
49. Vermeer S.E., Longstreth W.T., Koudstaal P.J. Silent brain infarcts: a systematic review. Lancet Neurol 2007, 6(7):611-619.
50. Zhu Y.C., Dufouil C., Tzourio C., et al. Silent brain infarcts: a review of MRI diagnostic criteria. Stroke 2011, 42(4):1140-1145.
51. Shima H., Ishimura E., Naganuma T., et al. Decreased kidney function is a significant factor associated with silent cerebral infarction and periventricular hyperintensities. Kidney Blood Press Res 2011, 34(6):430-438.
52. Cheung N., Mosley T., Islam A., et al. Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: a prospective study. Brain 2010, 133(Pt 7):1987-1993.
53. Groeschel S., Chong W.K., Surtees R., et al. Virchow-Robin spaces on magnetic resonance images: normative data, their dilatation, and a review of the literature. Neuroradiology 2006, 48(10):745-754.
54. Zhu Y.C., Tzourio C., Soumare A., et al. Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: a population-based study. Stroke 2010, 41(11):2483-2490.
55. Doubal F.N., MacLullich A.M., Ferguson K.J., et al. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke 2010, 41(3):450-454.
56. Maclullich A.M., Wardlaw J.M., Ferguson K.J., et al. Enlarged perivascular spaces are associated with cognitive function in healthy elderly men. JNeurol Neurosurg Psychiatry 2004, 75(11):1519-1523.
57. Zhu Y.C., Dufouil C., Soumare A., et al. High degree of dilated Virchow-Robin spaces on MRI is associated with increased risk of dementia. JAlzheimers Dis 2010, 22(2):663-672.
58. Zhu Y.C., Dufouil C., Mazoyer B., et al. Frequency and location of dilated Virchow-Robin spaces in elderly people: a population-based 3D MR imaging study. AJNR Am J Neuroradiol 2011, 32(4):709-713.
59. Bastos-Leite A.J., van Waesberghe J.H., Oen A.L., et al. Hippocampal sulcus width and cavities: comparison between patients with Alzheimer disease and nondemented elderly subjects. AJNR Am J Neuroradiol 2006, 27(10):2141-2145.
60. McKhann G., Drachman D., Folstein M., et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34(7):939-944.
61. McKhann G.M., Knopman D.S., Chertkow H., et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7:263-269.
62. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991, 82(4):239-259.
63. Barkhof F., Fox N., Bastos Leite A.J., et al. Neuroimaging in dementia 2011, Springer-Verlag, Berlin, Heidelberg (Germany).
64. Kramer J.H., Miller B.L. Alzheimer's disease and its focal variants. Semin Neurol 2000, 20(4):447-454.
65. Laakso M.P., Soininen H., Partanen K., et al. MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging 1998, 19(1):23-31.
66. Du A.T., Schuff N., Amend D., et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. JNeurol Neurosurg Psychiatry 2001, 71(4):441-447.
67. Shi F., Liu B., Zhou Y., et al. Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: meta-analyses of MRI studies. Hippocampus 2009, 19(11):1055-1064.
68. Achterberg H.C., van der Lijn F., den Heijer T., et al. Prediction of dementia by hippocampal shape analysis. Machine learning in medical imaging 2010, 42-49. Springer, Beijing (China). 1st edition. F. Wang, P. Yan, K. Suzuki (Eds.).
69. Costafreda S.G., Dinov I.D., Tu Z., et al. Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage 2011, 56(1):212-219.
70. Scheltens P., Leys D., Barkhof F., et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. JNeurol Neurosurg Psychiatry 1992, 55(10):967-972.
71. Wahlund L.O., Julin P., Johansson S.E., et al. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. JNeurol Neurosurg Psychiatry 2000, 69(5):630-635.
72. Petrella J.R., Coleman R.E., Doraiswamy P.M. Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology 2003, 226(2):315-336.
73. Scheltens P., Launer L.J., Barkhof F., et al. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. JNeurol 1995, 242(9):557-560.
74. Scheltens P., Fox N., Barkhof F., et al. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol 2002, 1(1):13-21.
75. Wahlund L.-O., Almkvist O., Blennow K., et al. Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup. Top Magn Reson Imaging 2005, 16(6):427-437.
76. Migliaccio R., Agosta F., Rascovsky K., et al. Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology 2009, 73(19):1571-1578.
77. Frisoni G.B., Testa C., Sabattoli F., et al. Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study. JNeurol Neurosurg Psychiatry 2005, 76(1):112-114.
78. Karas G., Scheltens P., Rombouts S., et al. Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study. Neuroradiology 2007, 49(12):967-976.
79. Renner J.A., Burns J.M., Hou C.E., et al. Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology 2004, 63(7):1175-1180.
80. Seguin J., Formaglio M., Perret-Liaudet A., et al. CSF biomarkers in posterior cortical atrophy. Neurology 2011, 76(21):1782-1788.
81. Tenovuo O., Kemppainen N., Aalto S., et al. Posterior cortical atrophy: a rare form of dementia with invivo evidence of amyloid-beta accumulation. J Alzheimers Dis 2008, 15(3):351-355.
82. Goethals M., Santens P. Posterior cortical atrophy. Two case reports and a review of the literature. Clin Neurol Neurosurg 2001, 103(2):115-119.
83. Caine D. Posterior cortical atrophy: a review of the literature. Neurocase 2004, 10(5):382-385.
84. Gorno-Tempini M.L., Dronkers N.F., Rankin K.P., et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004, 55(3):335-346.
85. Henry M.L., Gorno-Tempini M.L. The logopenic variant of primary progressive aphasia. Curr Opin Neurol 2010, 23(6):633-637.
86. Bonner M.F., Ash S., Grossman M. The new classification of primary progressive aphasia into semantic, logopenic, or nonfluent/agrammatic variants. Curr Neurol Neurosci Rep 2010, 10(6):484-490.
87. Young G.S., Geschwind M.D., Fischbein N.J., et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005, 26(6):1551-1562.
88. Tschampa H.J., Kallenberg K., Urbach H., et al. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain 2005, 128(Pt 9):2026-2033.
89. Schröter A., Zerr I., Henkel K., et al. Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch Neurol 2000, 57(12):1751-1757.
90. Román G.C., Tatemichi T.K., Erkinjuntti T., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993, 43(2):250-260.
91. van Straaten E.C., Scheltens P., Knol D.L., et al. Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study. Stroke 2003, 34(8):1907-1912.
92. van Straaten E.C., Scheltens P., Barkhof F. MRI and CT in the diagnosis of vascular dementia. JNeurol Sci 2004, 226(1-2):9-12.
93. Small G.W., Bookheimer S.Y., Thompson P.M., et al. Current and future uses of neuroimaging for cognitively impaired patients. Lancet Neurol 2008, 7(2):161-172.
94. Knudsen K.A., Rosand J., Karluk D., et al. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 2001, 56(4):537-539.
95. Rumboldt Z., Marotti M. Magnetization transfer, HASTE, and FLAIR imaging. Magn Reson Imaging Clin N Am 2003, 11(3):471-492.
96. Bastos Leite A.J., van Straaten E.C., Scheltens P., et al. Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging. Stroke 2004, 35(2):415-419.